Zhang X, Boyar W, Galakatos N, Gonnella N C
Ciba-Geigy Corporation, Pharmaceuticals Division, Summit, New Jersey 07901, USA.
Protein Sci. 1997 Jan;6(1):65-72. doi: 10.1002/pro.5560060107.
The tertiary structure of a unique C5a receptor antagonist was determined by two-dimensional NMR spectroscopy. The core domain of this 8-kDa antagonist exists as an antiparallel helical bundle, similar to recombinant human (rh)-C5a. However, unlike C5a, the antagonist's C terminus was found to be conformationally restricted along a groove between helices one and four in the core domain. This conformational restriction situates C-terminal D-Arg 75 in a wedge between core residues Arg 46 and His 15. Correlation of the antagonist's tertiary structure with point mutation analysis revealed the formation of a positively charged contiguous contact surface comprised of D-Arg 75, Arg 46, Lys 49, and His 15. The significance of this surface in generating antagonist properties implies a single binding site with the C5a receptor and provides a structural template for drug design.
一种独特的C5a受体拮抗剂的三级结构通过二维核磁共振光谱法得以确定。这种8 kDa拮抗剂的核心结构域以反平行螺旋束的形式存在,类似于重组人(rh)-C5a。然而,与C5a不同的是,发现该拮抗剂的C末端在核心结构域中沿着螺旋一和螺旋四之间的凹槽在构象上受到限制。这种构象限制使C末端的D-精氨酸75位于核心残基精氨酸46和组氨酸15之间的楔形区域。拮抗剂的三级结构与点突变分析的相关性揭示了由D-精氨酸75、精氨酸46、赖氨酸49和组氨酸15组成的带正电荷的连续接触表面的形成。该表面在产生拮抗剂特性方面的重要性意味着与C5a受体有一个单一的结合位点,并为药物设计提供了一个结构模板。